HealthEquity/HQY

$80.89

1.3%
-
1D1W1MYTD1YMAX

About HealthEquity

HealthEquity, Inc. is engaged in providing technology-enabled services that help consumers make healthcare savings and spending decisions. The Company uses its technology to manage consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members. It offers multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices.

Ticker

HQY

Sector

Technology

Trading on

NASDAQ

Industry

Software & Programming

CEO

Jon Kessler

Employees

3,126

Headquarters

Draper, United States

HealthEquity Metrics

BasicAdvanced
$6.88B
Market cap
124.97
P/E ratio
$0.64
EPS
0.55
Beta
-
Dividend rate
$6.88B
0.54962
$84.49
$48.86
578.57K
4.761
42.996
42.996
45.18
3.04%
1.78%
2.83%
1.86%
124.971
6.884
3.38
34.975
16%
305.92%
10.86%
76.39%

What the Analysts think about HealthEquity

Analyst Ratings

Majority rating from 14 analysts.
Buy

Price Targets

Average projection from 13 analysts.
22.67% upside
High $110.00
Low $92.00
$80.89
Current price
$99.23
Average price target

HealthEquity Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.02% profit margin
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$262.3M
5.26%
Net income
$26.3M
80.14%
Profit margin
10.02%
71.28%

HealthEquity Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 11.58%
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
$0.50
$0.53
$0.60
$0.63
-
Expected
$0.41
$0.48
$0.50
$0.56
$0.66
Surprise
23.2%
10.99%
20%
11.58%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for HealthEquity stock?

HealthEquity (HQY) has a market cap of $6.88B as of April 20, 2024.

What is the P/E ratio for HealthEquity stock?

The price to earnings (P/E) ratio for HealthEquity (HQY) stock is 124.97 as of April 20, 2024.

Does HealthEquity stock pay dividends?

No, HealthEquity (HQY) stock does not pay dividends to its shareholders as of April 20, 2024.

When is the next HealthEquity dividend payment date?

HealthEquity (HQY) stock does not pay dividends to its shareholders.

What is the beta indicator for HealthEquity?

HealthEquity (HQY) has a beta rating of 0.55. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the HealthEquity stock price target?

The target price for HealthEquity (HQY) stock is $99.23, which is 22.67% above the current price of $80.89. This is an average based on projections from 13 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell HealthEquity stock

Buy or sell HealthEquity stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing